Denali Therapeutics DNLI
NASDAQ DNLI
$20.00 -0.53 (-2.58%)
At close: Oct 2, 2026 · 4:00 PM EDT

Denali Therapeutics (DNLI) Interest & Investment Income (2023 - 2026)

Updated

Denali Therapeutics' Interest & Investment Income came in at $2.99 million for Q2 2026, down 72.4% from $10.84 million a year earlier and down 66.5% from the prior quarter.

Analysis

Denali Therapeutics (DNLI) Interest & Investment Income (2023 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Denali Therapeutics reported Interest & Investment Income of $31.35 million, down 42.6% year-over-year; for FY2025, it came in at $42.9 million, down 33.6% from FY2024.

  • Interest & Investment Income carries a three-year compound annual growth rate of 42.7% (FY2022 to FY2025).
  • Going back by year, Interest & Investment Income was $64.64 million in FY2024 (+25.5%), $51.51 million in FY2023 (+248.6%) and $14.77 million in FY2022.
  • The Q2 2026 figure represents the lowest quarterly Interest & Investment Income in data going back to Q1 2023.
  • Year-over-year, Interest & Investment Income has declined for six consecutive quarters, with an average decline of 26.2% over the last eight quarters.
  • The fastest year-over-year change in Interest & Investment Income over five years came in Q1 2024 (growth of 44.2%), and the weakest in Q2 2026 (a decline of 72.4%).
  • Business Quant data shows DNLI's Interest & Investment Income at $8.91 million (Q1 2026), $8.92 million (Q4 2025) and $10.53 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 219.00 Mn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 80.00 Mn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Denali Therapeutics 3.20 Bn 3.20 Bn 3.51 Mn 2.99 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.99 Mn
Mar 31, 2026 8.91 Mn
Dec 31, 2025 8.92 Mn
Sep 30, 2025 10.53 Mn
Jun 30, 2025 10.84 Mn
Mar 31, 2025 12.61 Mn
Dec 31, 2024 15.16 Mn
Sep 30, 2024 16.00 Mn
Jun 30, 2024 17.57 Mn
Mar 31, 2024 15.91 Mn
Dec 31, 2023 13.13 Mn
Sep 30, 2023 14.44 Mn
Jun 30, 2023 12.90 Mn
Mar 31, 2023 11.03 Mn
API Access

Denali Therapeutics Interest & Investment Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=DNLI&period=max&api_key=YOUR_API_KEY